Gary Charles Robb - Dec 4, 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Stock symbol
CORT
Transactions as of
Dec 4, 2023
Transactions value $
-$385,486
Form type
4
Date filed
12/6/2023, 08:56 PM
Previous filing
Dec 5, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $49.4K +15K +65.87% $3.29* 37.8K Dec 4, 2023 Direct F1
transaction CORT Common Stock Tax liability -$231K -8.79K -23.27% $26.26 29K Dec 4, 2023 Direct F1, F2
transaction CORT Common Stock Sale -$36.3K -1.38K -4.76% $26.27 27.6K Dec 5, 2023 Direct F1
transaction CORT Common Stock Sale -$168K -6.21K -22.51% $27.01 21.4K Dec 6, 2023 Direct F1
holding CORT Common Stock 8.06K Dec 4, 2023 Custodial Account for Child F3
holding CORT Common Stock 8.06K Dec 4, 2023 Custodial Account for Child F3
holding CORT Common Stock 8.06K Dec 4, 2023 Custodial Account for Child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -15K -19.73% $0.00 61K Dec 4, 2023 Common Stock 15K $3.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2 These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on December 4, 2023. The options subject to the net exercise were to expire on February 18, 2025.
F3 These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F4 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.